Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Research & Development: 2018-2024

Historic Research & Development for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $592.2 million.

  • Revolution Medicines' Research & Development rose 72.98% to $262.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $880.5 million, marking a year-over-year increase of 59.17%. This contributed to the annual value of $592.2 million for FY2024, which is 39.96% up from last year.
  • Latest data reveals that Revolution Medicines reported Research & Development of $592.2 million as of FY2024, which was up 39.96% from $423.1 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Research & Development ranged from a high of $592.2 million in FY2024 and a low of $132.3 million during FY2020.
  • For the 3-year period, Revolution Medicines' Research & Development averaged around $422.8 million, with its median value being $423.1 million (2023).
  • Data for Revolution Medicines' Research & Development shows a peak YoY surged of 67.20% (in 2023) over the last 5 years.
  • Over the past 5 years, Revolution Medicines' Research & Development (Yearly) stood at $132.3 million in 2020, then surged by 41.36% to $186.9 million in 2021, then skyrocketed by 35.37% to $253.1 million in 2022, then soared by 67.20% to $423.1 million in 2023, then spiked by 39.96% to $592.2 million in 2024.